These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19289131)

  • 21. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.
    Driscoll MD; Golinelli MP; Hughes SH
    J Virol; 2001 Jan; 75(2):672-86. PubMed ID: 11134281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance.
    Delviks-Frankenberry KA; Nikolenko GN; Barr R; Pathak VK
    J Virol; 2007 Jul; 81(13):6837-45. PubMed ID: 17428874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge neutralization of RNA/DNA hybrids.
    Dash C; Scarth BJ; Badorrek C; Götte M; Le Grice SF
    Nucleic Acids Res; 2008 Nov; 36(20):6363-71. PubMed ID: 18836193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus reverse transcriptase ribonuclease H: specificity of tRNA(Lys3)-primer excision.
    Furfine ES; Reardon JE
    Biochemistry; 1991 Jul; 30(29):7041-6. PubMed ID: 1713059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus-strand primer, tRNA(Lys3).
    Smith JS; Roth MJ
    J Biol Chem; 1992 Jul; 267(21):15071-9. PubMed ID: 1378844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence requirements for removal of tRNA by an isolated human immunodeficiency virus type 1 RNase H domain.
    Smith CM; Leon O; Smith JS; Roth MJ
    J Virol; 1998 Aug; 72(8):6805-12. PubMed ID: 9658129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors.
    Su HP; Yan Y; Prasad GS; Smith RF; Daniels CL; Abeywickrema PD; Reid JC; Loughran HM; Kornienko M; Sharma S; Grobler JA; Xu B; Sardana V; Allison TJ; Williams PD; Darke PL; Hazuda DJ; Munshi S
    J Virol; 2010 Aug; 84(15):7625-33. PubMed ID: 20484498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase.
    DeStefano JJ; Mallaber LM; Fay PJ; Bambara RA
    Nucleic Acids Res; 1993 Sep; 21(18):4330-8. PubMed ID: 7692401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helix structure and ends of RNA/DNA hybrids direct the cleavage specificity of HIV-1 reverse transcriptase RNase H.
    Palaniappan C; Fuentes GM; Rodríguez-Rodríguez L; Fay PJ; Bambara RA
    J Biol Chem; 1996 Jan; 271(4):2063-70. PubMed ID: 8567660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation.
    Beilhartz GL; Ngure M; Johns BA; DeAnda F; Gerondelis P; Götte M
    J Biol Chem; 2014 Jun; 289(23):16270-7. PubMed ID: 24719329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiation.
    Biondi MJ; Beilhartz GL; McCormick S; Götte M
    J Biol Chem; 2010 Aug; 285(35):26966-26975. PubMed ID: 20530477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase.
    Stahl SJ; Kaufman JD; Vikić-Topić S; Crouch RJ; Wingfield PT
    Protein Eng; 1994 Sep; 7(9):1103-8. PubMed ID: 7530360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.
    Oh J; McWilliams MJ; Julias JG; Hughes SH
    J Virol; 2008 Jan; 82(2):719-27. PubMed ID: 17989171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.
    Mbisa JL; Nikolenko GN; Pathak VK
    J Virol; 2005 Jan; 79(1):419-27. PubMed ID: 15596835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that HIV-1 reverse transcriptase employs the DNA 3' end-directed primary/secondary RNase H cleavage mechanism during synthesis and strand transfer.
    Purohit V; Balakrishnan M; Kim B; Bambara RA
    J Biol Chem; 2005 Dec; 280(49):40534-43. PubMed ID: 16221683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
    Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
    Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of RNA secondary structure on RNA cleavage catalyzed by HIV-1 reverse transcriptase.
    Suo Z; Johnson KA
    Biochemistry; 1997 Oct; 36(41):12468-76. PubMed ID: 9376351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids.
    Wöhrl BM; Moelling K
    Biochemistry; 1990 Nov; 29(44):10141-7. PubMed ID: 1703002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid.
    Shaw-Reid CA; Munshi V; Graham P; Wolfe A; Witmer M; Danzeisen R; Olsen DB; Carroll SS; Embrey M; Wai JS; Miller MD; Cole JL; Hazuda DJ
    J Biol Chem; 2003 Jan; 278(5):2777-80. PubMed ID: 12480948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.